Use este identificador para citar ou linkar para este item:
https://www.arca.fiocruz.br/handle/icict/15989
Tipo de documento
ArtigoDireito Autoral
Acesso aberto
Data de embargo
2021-01-01
Coleções
Metadata
Mostrar registro completo
A NEXT-GENERATION PROTEOME ARRAY FOR SCHISTOSOMA MANSONI
Autor(es)
Afiliação
Fundação Oswaldo Cruz. Centro de Pesquisa Rene Rachou. Laboratório de Imunologia Celular e Molecular. Belo Horizonte, MG, Brazil/ University of California. School of Medicine. Division of Infectious Disease. Protein Microarray Laboratory. Irvine, CA, USA
Universidade Federal de Minas Gerais. Faculdade de Medicina. Infectologia e Medicina Tropical. Belo Horizonte, MG, Brasil
University of California. School of Medicine. Division of Infectious Disease. Protein Microarray Laboratory. Irvine, CA, USA
University of California. School of Medicine. Division of Infectious Disease. Protein Microarray Laboratory. Irvine, CA, USA
Vale Technology Institute of Sustainable Development. Belém, PA, Brazil
University of California. School of Medicine. Division of Infectious Disease. Protein Microarray Laboratory. Irvine, CA, USA
Fundação Oswaldo Cruz. Centro de Pesquisa Rene Rachou. Laboratório de Imunologia Celular e Molecular. Belo Horizonte, MG, Brazil
James Cook University. Australian Institute of Tropical Health & Medicine. Centre for Biodiscovery and Molecular Development of Therapeutics. Cairns, QLD, Australia
University of Texas Health Science Center. School of Medicine. Departments of Biochemistry and Pathology. San Antonio, TX , USA
Fundação Oswaldo Cruz. Centro de Pesquisa Rene Rachou. Laboratório de Imunologia Celular e Molecular. Belo Horizonte, MG, Brazil/The George Washington University. School of Medicine and Health Science. Department of Microbiology, Immunology, and Tropical Medicine. Washington, DC, USA
Fundação Oswaldo Cruz. Centro de Pesquisa Rene Rachou. Laboratório de Imunologia Celular e Molecular. Belo Horizonte, MG, Brazil
Fundação Oswaldo Cruz. Centro de Pesquisa Rene Rachou. Laboratório de Imunologia Celular e Molecular. Belo Horizonte, MG, Brazil/ University of California. School of Medicine. Division of Infectious Disease. Protein Microarray Laboratory. Irvine, CA, USA
Universidade Federal de Minas Gerais. Faculdade de Medicina. Infectologia e Medicina Tropical. Belo Horizonte, MG, Brasil
University of California. School of Medicine. Division of Infectious Disease. Protein Microarray Laboratory. Irvine, CA, USA
University of California. School of Medicine. Division of Infectious Disease. Protein Microarray Laboratory. Irvine, CA, USA
Vale Technology Institute of Sustainable Development. Belém, PA, Brazil
University of California. School of Medicine. Division of Infectious Disease. Protein Microarray Laboratory. Irvine, CA, USA
Fundação Oswaldo Cruz. Centro de Pesquisa Rene Rachou. Laboratório de Imunologia Celular e Molecular. Belo Horizonte, MG, Brazil
James Cook University. Australian Institute of Tropical Health & Medicine. Centre for Biodiscovery and Molecular Development of Therapeutics. Cairns, QLD, Australia
University of Texas Health Science Center. School of Medicine. Departments of Biochemistry and Pathology. San Antonio, TX , USA
Fundação Oswaldo Cruz. Centro de Pesquisa Rene Rachou. Laboratório de Imunologia Celular e Molecular. Belo Horizonte, MG, Brazil/The George Washington University. School of Medicine and Health Science. Department of Microbiology, Immunology, and Tropical Medicine. Washington, DC, USA
Fundação Oswaldo Cruz. Centro de Pesquisa Rene Rachou. Laboratório de Imunologia Celular e Molecular. Belo Horizonte, MG, Brazil
Fundação Oswaldo Cruz. Centro de Pesquisa Rene Rachou. Laboratório de Imunologia Celular e Molecular. Belo Horizonte, MG, Brazil/ University of California. School of Medicine. Division of Infectious Disease. Protein Microarray Laboratory. Irvine, CA, USA
Resumo em Inglês
A proteome microarray consisting of 992 Schistosoma mansoni proteins was produced and screened with sera to determine antibody signatures indicative of the clinical stages of schistosomiasis and the identification of subunit vaccine candidates. Herein, we describe the methods used to derive the gene list for this array (representing approximately 10% of the predicted S. mansoni proteome). We also probed a pilot version of the microarray with sera from individuals either acutely or chronically infected with S. mansoni from endemic areas in Brazil and sera from individuals resident outside the endemic area (USA) to determine if the array is functional and informative.
Compartilhar